Reference
Rucaparib (Rubraca): withdrawal of third-line treatment indication Internet Document : 29 Sep 2022. Available from: URL: https://www.gov.uk/drug-safety-update/rucaparib-rubracav-withdrawal-of-third-line-treatment-indication
Rights and permissions
About this article
Cite this article
Third-line indication for rucaparib withdrawn due to reduced survival. Reactions Weekly 1927, 8 (2022). https://doi.org/10.1007/s40278-022-24744-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-24744-5